Medical ProductsCompany
Nichi-Iko Pharmaceutical M&A Summary
Nichi-Iko Pharmaceutical has acquired 1 company.
Nichi-Iko Pharmaceutical’s largest acquisition to date was in 2016, when it acquired Sagent Pharmaceuticals for $736M. Nichi-Iko Pharmaceutical has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Nichi-Iko Pharmaceutical Business Overview
Where is Nichi-Iko Pharmaceutical headquartered?
Nichi-Iko Pharmaceutical is headquartered in Toyama, Japan.
What is Nichi-Iko Pharmaceutical’s revenue?
Nichi-Iko Pharmaceutical disclosed revenue of 179,060M JPY for 2022 and 188,218M JPY for 2021.
How many employees does Nichi-Iko Pharmaceutical have?
Nichi-Iko Pharmaceutical has 2,725 employees.
What sector is Nichi-Iko Pharmaceutical in?
Nichi-Iko Pharmaceutical is a medical products company.
When was Nichi-Iko Pharmaceutical founded?
Nichi-Iko Pharmaceutical was founded in 1965.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 4